TABLE 4. Type of tetanus vaccine received, and proportion that were tetanus, diphtheria, acellular pertussis vaccine, among adults aged ≥19 years, by selected characteristics — National Health Interview Survey, United States, 2015.
Characteristic | Type of tetanus toxoid-containing vaccine received during 2005–2015 |
Proportion that was Tdap of the total tetanus toxoid-containing vaccine during 2005–2015* |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
No. in sample | Received Tdap |
Received other tetanus vaccine |
Doctor did not inform the patient |
Could not recall vaccine type |
||||||||
% | (95% CI) | % | (95% CI) | % | (95% CI) | % | (95% CI) | No. in sample | % | (95% CI) | ||
Age group (yrs)
| ||||||||||||
≥19
| ||||||||||||
Total
|
16,996 |
27.6 |
(26.5–28.8) |
10.8 |
(10.0–11.5) |
49.1 |
(47.7–50.5) |
12.6 |
(11.7–13.5) |
6,550 |
72.0 |
(70.2–73.7) |
HCP† |
1,853 |
45.1 |
(42.1–48.2) |
12.6 |
(10.7–14.8) |
32.0 |
(28.9–35.2) |
10.3 |
(8.3–12.8) |
1,087 |
78.2§ |
(74.6–81.3) |
Non-HCP |
15,124 |
25.5 |
(24.3–26.7) |
10.5 |
(9.8–11.4) |
51.2 |
(49.7–52.6) |
12.8 |
(11.9–13.7) |
5,460 |
70.8 |
(68.7–72.7) |
19–64
| ||||||||||||
Total
|
13,224 |
28.9 |
(27.6–30.2) |
10.6 |
(9.9–11.5) |
47.8 |
(46.3–49.4) |
12.7 |
(11.7–13.7) |
5,295 |
73.1 |
(71.2–74.9) |
HCP |
1,658 |
46.3 |
(43.1–49.7) |
12.5 |
(10.5–14.8) |
31.0 |
(27.8–34.4) |
10.2 |
(8.0–12.8) |
998 |
78.8§ |
(75.0–82.1) |
Non-HCP |
11,548 |
26.4 |
(25.1–27.8) |
10.4 |
(9.5–11.3) |
50.2 |
(48.6–51.8) |
13.0 |
(12.0–14.0) |
4,294 |
71.8 |
(69.6–73.9) |
≥65
| ||||||||||||
Total
|
3,772 |
21.9 |
(20.0–23.9) |
11.3 |
(9.9–12.8) |
54.8 |
(52.5–57.2) |
12.0 |
(10.5–13.6) |
1,255 |
65.9 |
(62.2–69.4) |
HCP |
195 |
29.1 |
(20.8–39.2) |
14.2 |
(8.3–23.1) |
44.5 |
(35.4–54.0) |
12.1 |
(7.0–20.1) |
89 |
67.2 |
(50.8–80.3) |
Non-HCP | 3,576 | 21.5 | (19.6–23.6) | 11.2 | (9.8–12.8) | 55.3 | (52.9–57.7) | 12.0 | (10.5–13.6) | 1,166 | 65.8 | (62.0–69.5) |
Abbreviations: CI = confidence interval; HCP = health care personnel; Td = tetanus-diphtheria toxoid; Tdap = tetanus, diphtheria, and acellular pertussis vaccine
* Calculated by dividing the number of respondents who reported receiving Tdap by the sum of those who reported receiving Tdap and those who reported receiving other tetanus vaccination; respondents who reported that the doctor did not inform them of the vaccine type they received and those who could not recall the vaccine type were excluded.
† Adults were classified as HCP if they reported they currently volunteer or work in a hospital, medical clinic, doctor’s office, dentist’s office, nursing home or some other health care facility including part-time and unpaid work in a health care facility as well as professional nursing care provided in the home.
§ p<0.05 by T test for comparisons between HCP and non-HCP.